Gilead Sciences and Vir Biotechnology have significantly expanded their strategic research and development alliance through a newly finalized licensing agreement…
Read More
INmune Bio and Quantum Computing Inc. Join Forces in Milestone Partnership to Accelerate Drug Discovery for XPro Using Advanced Quantum Technology
Biotechnology innovator INmune Bio has entered into a landmark strategic partnership with Quantum Computing Inc. (QCi), marking QCi’s first-ever commercial…
Read More
FDA Unveils Rare Disease Framework Initiative to Accelerate Novel Therapies and Streamline Drug Development
The United States Food and Drug Administration (FDA) has officially rolled out the Rare Disease Framework Initiative, a sweeping regulatory…
Read More
Pfizer and Enodia Therapeutics Ink Multi-Million-Dollar Agreement to Advance Novel Sec61 Inhibitors in Major R&D Partnership
Pharmaceutical giant Pfizer has entered into a strategic research collaboration and licensing agreement with Enodia Therapeutics valued at upwards of…
Read More
Johnson and Johnson Raises 2026 Guidance for Sales and Earnings Despite Generic Headwinds and Major Legal and Acquisition Outlays
Johnson & Johnson has officially raised its financial projections for the full year 2026, demonstrating remarkable resilience in the face…
Read More
Perceptive Discovery and Nucleus RadioPharma Form Strategic Alliance to Streamline Radiopharmaceutical Development
The modern landscape of oncology and molecular imaging is undergoing a profound transformation, driven largely by the clinical promise of…
Read More
FDA Approves Asahi Kasei Therapeutics Hovilpri for Refractory Mucocutaneous Herpes Simplex Virus in Immunocompromised Adults
The United States Food and Drug Administration (FDA) has granted formal marketing approval for Hovilpri (pritelivir) 100mg tablets, developed by…
Read More
Teva Pharmaceutical Industries Secures FDA Approval for Weltruza, a Once-Monthly Injectable Olanzapine to Transform Schizophrenia Care
The landscape of neuropsychiatric care has reached a significant milestone following the United States Food and Drug Administration (FDA) approval…
Read More
FDA Approves Pfizer’s Tukysa Regimen as Frontline Maintenance Therapy for Advanced HER2-Positive Breast Cancer
The United States Food and Drug Administration (FDA) has granted regulatory approval to Pfizer’s targeted oncology medication Tukysa (tucatinib) in…
Read More
Biohaven and Ono Pharmaceutical Forge Up to $100m Licensing Deal for Advanced IgG Degrader Portfolio in Asia
The global biopharmaceutical landscape witnessed a significant strategic alliance as Biohaven Ltd. announced a landmark licensing and regional partnership agreement…
Read More
